Blood Test Study Shows Ability to Identify Healthy Individuals at High Risk for Alzheimer's Disease

A blood test measuring p-tau217 may predict the likelihood of developing Alzheimer’s symptoms within five to ten years in healthy older adults. High levels of p-tau217 are associated with increased risk, reaching up to 78% over a decade, but the test is not yet recommended for general screening. Researchers emphasize that current health advice remains unchanged, and the test's primary value is in advancing drug development and clinical trial enrollment.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل